Skip to main content

The Nordic Project on Renal Transplantation and Cancer

  • Conference paper
Cancer in Organ Transplant Recipients
  • 57 Accesses

Abstract

The feasibility of transplanting kidneys is a tremendous step forward in the treatment of uremic patients, but like all other medical conquests it has its price; one of the drawbacks is the risk of cancer. The theory that cancer arises in conditions of reduced immune capacity in the host was first put forward by Thomas (1959) and later developed in the theory of immune surveillance by Burnet (1964). Since then the theory has been supported by observations made in animal experiments and in reports from human clinical medicine involving patients with immune deficiencies, patients undergoing immunosuppressive treatment, and patients who have undergone kidney transplantation.

This study has been supported by Olga og Esper Boels Fond, A/S Fehr og Co’s Fond, Arvid Nilssons Fond, Ingenioer N.M. Knudsens Fond, Koebmand Sven Hansen og Hustru Ina Hansens Fond, Fonden af 1870, Familien Hede Nielsens Fond, Direktoer E. Danielsen og hustrus Fond, Mads Clausens Fond and S & W Fondet.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  • Barnes BA, Bergan JJ, Braun WE et al. (1977) The 13th report of the human renal transplant registry. Transplant Proc 9:9–26

    Google Scholar 

  • Birkeland SA (1982) The fate of kidney transplanted patients with a previous history of malignancy. The Scandinavian material. Scand J Urol Nephrol 16:283–286

    Article  PubMed  CAS  Google Scholar 

  • Birkeland SA (1983a) Cancer in cadaver kidney transplant patients. Surgery 93:504–507

    PubMed  CAS  Google Scholar 

  • Birkeland SA (1983b) Malignant tumours in renal transplant patients. The Scandia-transplant material. Cancer 51:1571–1575

    Article  PubMed  CAS  Google Scholar 

  • Birkeland SA (1983c) Chronic antigenic stimulation from the graft as a possible oncogenic factor after renal transplantation. Scand J Urol Nephrol 17:35–39

    Article  Google Scholar 

  • Birkeland SA (1983d) Cancer in transplanted patients. The Scandiatransplant material. Transplant Proc 15:1071–1078

    Google Scholar 

  • Birkeland SA (1985) Immune monitoring of tumour development after renal transplantation. Cancer 55:988–994

    Article  PubMed  CAS  Google Scholar 

  • Birkeland SA (1987) Common aspects on immunological tolerance in pregnancy, transplantation and cancer. In: Birkeland SA et al. (eds) Per aspera ad astra. Birkeland, Odense, Denmark, pp 74–87

    Google Scholar 

  • Birkeland SA et al. (1973) Malignant tumours following immunosuppression in renal transplantation. Proc EDTA 10:429–433

    CAS  Google Scholar 

  • Birkeland SA, Hauge M et al. (1975) Renal transplantation and cancer, the Scandia-transplant material. Tissue Antigens 6:28–36

    Article  PubMed  CAS  Google Scholar 

  • Birkeland SA, Hauge M et al. (1977) Cancer as a late-onset complication of kidney transplantation. Scand J Urol Nephrol (suppl) 42:179–183

    Google Scholar 

  • Birkeland SA, Hauge M et al. (1980) Renal transplantation and cáncer in Scandia-transplant material. Scand J Urol Nephrol (suppl) 54:11–15

    CAS  Google Scholar 

  • Burnet FM (1964) Immunological factors in the process of carcinogenesis. Br Med Bull 20:154–158

    PubMed  CAS  Google Scholar 

  • Haukulinen T, Andersen AA, Malker B, Pukkala E, Schou G, Tulinius H (1986) Trends in cancer incidence in the nordic countries. A Collaborative study of the five nordic cancer registries. APMIS Sect A (suppl 288) 288:1–151

    Google Scholar 

  • Hoover R, Fraumeni JF (1973) Risk of cancer in renal-transplant recipients. Lancet ii: 55–57

    Article  Google Scholar 

  • Lynge E, Holm N (1989) Cancerepidemiologi, Mânedskr Prakt Lægeger 67: 733–784

    Google Scholar 

  • Penn I (1975) The incidence of malignancies in transplant recipients. Transplant Proc 7:323–326

    PubMed  CAS  Google Scholar 

  • Peen I (1978a) Development of cancer in transplantation patients. Adv Surg 12:155–191

    Google Scholar 

  • Penn I (1978b) Immunosuppression and malignant disease. In: Twomey JJ, Good RA (eds) The immunopathology of lymphoreticular neoplasms. Comprehensive Immunology, NY, pp 223–237

    Chapter  Google Scholar 

  • Penn I (1981) Malignant lymphomas in organ transplant recipients. Transplant Proc 13:736–738

    PubMed  CAS  Google Scholar 

  • Penn I (1986) Cancer is a complication in severe immunosuppression. Surg Gynecol Obstet 162:603–610

    PubMed  CAS  Google Scholar 

  • Penn I (1988) Cancer after cyclosporine therapy. Transplant Proc 20:276–279

    PubMed  CAS  Google Scholar 

  • Penn I (1989) Risk of cancer in the transplant patient. In: Flye MW (ed) Principles of organ transplantation. Saunders, Philadelphia, pp 634–643

    Google Scholar 

  • Penn I, Brunson ME (1988) Cancer after cyclosporine therapy 20:885–892

    CAS  Google Scholar 

  • Penn I, Starzl TE (1973) The effect of immunosuppression on cancer. Seventh Natl Cancer Conf Proc Lippincott, Philadelphia, pp 425–436

    Google Scholar 

  • Penn I, Hammond W, Brettschneider L, Starzl TE (1969) Malignant lymphomas in transplanted patients. Transplant Proc 1:106–112

    PubMed  CAS  Google Scholar 

  • Polson RJ, Neuberger J, Forman D, Calne R, Williams R (1988) De novo malignancies after liver transplantation. Transplant Proc 20:94–97

    PubMed  CAS  Google Scholar 

  • Sheil AGR (1986) Cancer after transplantation. World J Surg 10:389–396

    Article  PubMed  CAS  Google Scholar 

  • Sheil AGR, Mahoney JF, Horvath JS, Johnson JR, Tiller DJ, May J, Stewart JH (1979) Cancer and survival after cadaveric donor renal transplantation. Transplant Proc 11:1052–1054

    PubMed  CAS  Google Scholar 

  • Sheil AGR, Mahoney JF, Horvath JS, Johnson JR, Tiller DJ, Stewart JH, May J (1981) Cancer following successful cadaveric donor renal transplantation. Transplant Proc 13:733–735

    PubMed  CAS  Google Scholar 

  • Starzl TE, Groth C-G, Brettschneider L, Smith GV, Penn I, Kashiwagi N (1968) Perspectives in organ transplantation. Antibiot Chemother (Basel) 15:349

    Google Scholar 

  • Storm HH, Sprøgel P, Bang S, Jensen OM (1989) Cancer incidence in Denmark 1986. Danish Cancer Society, Danish Cancer incidence in Denmark 1986. Danish Cancer Society, Danish Cancer Registry. Danish Cancer Society. Copenhagen

    Google Scholar 

  • Thomas L (1959) Discussion. Cellular and humoral aspects of the hypersensitive states. Lawrence HS (ed) Hoeber-Harper, New York, p 529

    Google Scholar 

  • Waterhouse J, Muir C, Correa P, Powell J (1976) Cancer incidence in five continents. Vol 3 IARC Scientific Publications No. 15. International Agency for Research on Cancer, Lyons

    Google Scholar 

  • Weintraub J, Warnke RA (1982) Lymphoma in cardiac allotransplant recipients. Transplantation 33:347–351

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Birkeland, S.A. (1991). The Nordic Project on Renal Transplantation and Cancer. In: Schmähl, D., Penn, I. (eds) Cancer in Organ Transplant Recipients. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-75991-8_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-75991-8_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-53020-6

  • Online ISBN: 978-3-642-75991-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics